ES2180807T3 - Procedimiento y dispositivo para la obtencion de una preparacion medicamentosa parenteral. - Google Patents

Procedimiento y dispositivo para la obtencion de una preparacion medicamentosa parenteral.

Info

Publication number
ES2180807T3
ES2180807T3 ES96938066T ES96938066T ES2180807T3 ES 2180807 T3 ES2180807 T3 ES 2180807T3 ES 96938066 T ES96938066 T ES 96938066T ES 96938066 T ES96938066 T ES 96938066T ES 2180807 T3 ES2180807 T3 ES 2180807T3
Authority
ES
Spain
Prior art keywords
procedure
obtaining
homogenizer
bar
medicinal preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96938066T
Other languages
English (en)
Spanish (es)
Inventor
Bernd Klinksiek
Said Mahiout
Ricarda-Christine Nothelle
Hans-Jurgen Hamann
Jurgen Sdebik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2180807T3 publication Critical patent/ES2180807T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/40—Static mixers
    • B01F25/46—Homogenising or emulsifying nozzles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/70—Mixers specially adapted for working at sub- or super-atmospheric pressure, e.g. combined with de-foaming
    • B01F33/71—Mixers specially adapted for working at sub- or super-atmospheric pressure, e.g. combined with de-foaming working at super-atmospheric pressure, e.g. in pressurised vessels
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ES96938066T 1995-11-15 1996-11-04 Procedimiento y dispositivo para la obtencion de una preparacion medicamentosa parenteral. Expired - Lifetime ES2180807T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19542499A DE19542499A1 (de) 1995-11-15 1995-11-15 Verfahren und Vorrichtung zur Herstellung einer parenteralen Arzneistoffzubereitung

Publications (1)

Publication Number Publication Date
ES2180807T3 true ES2180807T3 (es) 2003-02-16

Family

ID=7777475

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96938066T Expired - Lifetime ES2180807T3 (es) 1995-11-15 1996-11-04 Procedimiento y dispositivo para la obtencion de una preparacion medicamentosa parenteral.

Country Status (11)

Country Link
US (1) US6331314B1 (enExample)
EP (1) EP0861068B1 (enExample)
JP (1) JP4049391B2 (enExample)
AT (1) ATE222097T1 (enExample)
CA (1) CA2237554C (enExample)
DE (2) DE19542499A1 (enExample)
DK (1) DK0861068T3 (enExample)
ES (1) ES2180807T3 (enExample)
MX (1) MX9803633A (enExample)
PT (1) PT861068E (enExample)
WO (1) WO1997017946A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2216423T3 (es) 1998-12-07 2004-10-16 Dsm Ip Assets B.V. Metodo y dispositivo para mezclar o dispersar liquidos.
US20020119188A1 (en) * 2000-02-08 2002-08-29 Susan Niemiec Method of manufacturing liposomes
EP1222957A1 (en) * 2000-12-22 2002-07-17 Société des Produits Nestlé S.A. Process and device for producing a food grade oil-in-water emulsion
DE102004055507A1 (de) * 2004-11-17 2006-05-18 Basf Ag Verfahren zur Herstellung feinteiliger flüssig-flüssig Formulierungen und Vorrichtung zur Herstellung feinteiliger flüssig-flüssig Formulierungen
WO2007111937A1 (en) * 2006-03-23 2007-10-04 Applera Corporation Directed enrichment of genomic dna for high-throughput sequencing
US7985058B2 (en) * 2007-01-12 2011-07-26 Mark Gray Method and apparatus for making uniformly sized particles
US7479576B1 (en) * 2007-06-27 2009-01-20 H R D Corporation Method of hydrogenating aldehydes and ketones
US7652175B2 (en) * 2007-06-27 2010-01-26 H R D Corporation High shear process for the production of acetaldehyde
US7491856B2 (en) 2007-06-27 2009-02-17 H R D Corporation Method of making alkylene glycols
US8304584B2 (en) 2007-06-27 2012-11-06 H R D Corporation Method of making alkylene glycols
CN101687153A (zh) * 2007-06-28 2010-03-31 宝洁公司 通过产生剪切和/或气穴进行混合的设备和方法以及用于设备的组件
US8322910B2 (en) 2008-07-25 2012-12-04 The Procter & Gamble Company Apparatus and method for mixing by producing shear and/or cavitation, and components for apparatus
CN101617990B (zh) * 2009-07-31 2013-01-23 中国人民解放军第三军医大学 脂质体制备装置以及使用该装置制备脂质体的方法
JP5771366B2 (ja) 2009-09-02 2015-08-26 株式会社バイオメッドコア リポソーム製造装置及び方法
DE102009056884B4 (de) * 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
EP2506834B1 (en) 2009-12-03 2016-03-02 Novartis AG Circulation of components during homogenization and microfluidization of emulsions
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056871A1 (de) 2009-12-03 2011-06-22 Novartis AG, 4056 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
CN104688687A (zh) 2009-12-03 2015-06-10 诺华股份有限公司 疫苗佐剂制备中的亲水过滤
CL2012001399A1 (es) 2009-12-03 2013-03-08 Novartis Ag Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion.
CN120529961A (zh) * 2023-01-17 2025-08-22 帝斯曼知识产权资产管理有限公司 液体分散体制备工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529561A (en) * 1978-03-24 1985-07-16 The Regents Of The University Of California Method for producing liposomes in selected size range
WO1983000089A1 (en) * 1981-07-06 1983-01-20 Rush Presbyterian St Luke Preparation of synthetic erythrocytes
CA1264668A (en) * 1984-06-20 1990-01-23 Pieter R. Cullis Extrusion techniques for producing liposomes
DE3515335C2 (de) 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE4207481A1 (de) * 1992-03-10 1993-09-16 Bayer Ag Liposomale wirkstoff-formulierungen und verfahren zu ihrer herstellung
JPH08505312A (ja) 1992-10-16 1996-06-11 ザックセ，アンドレアス 液状分散系を製造する方法及び装置
DE4328331A1 (de) * 1993-08-18 1995-02-23 Andreas Dr Sachse Kontinuierliches Hochdruckextrusionsverfahren zur Herstellung von Liposomen und Emulsionen

Also Published As

Publication number Publication date
JP2000500146A (ja) 2000-01-11
EP0861068B1 (de) 2002-08-14
DE59609564D1 (de) 2002-09-19
PT861068E (pt) 2002-12-31
MX9803633A (es) 1998-09-30
EP0861068A2 (de) 1998-09-02
JP4049391B2 (ja) 2008-02-20
DE19542499A1 (de) 1997-05-22
CA2237554A1 (en) 1997-05-22
CA2237554C (en) 2007-01-09
US6331314B1 (en) 2001-12-18
DK0861068T3 (da) 2002-12-02
WO1997017946A2 (de) 1997-05-22
WO1997017946A3 (de) 1997-09-12
ATE222097T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
ES2180807T3 (es) Procedimiento y dispositivo para la obtencion de una preparacion medicamentosa parenteral.
TW347339B (en) Oral delivery of discrete units
AU5230299A (en) Injection-assisting probe for medical injector assembly
HUP0000520A2 (hu) Új vizes gyógyszerkészítmények hajtógázmentes aeroszolokhoz
AR032132A1 (es) Composicion farmaceutica que comprende una combinacion de un compuesto de tramadol y una droga anticonvulsiva y uso de la combinacion para preparar un medicamento
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
AR013442A1 (es) Proceso para preparar una dispersion de politetrafluroetileno.
CO5540369A2 (es) Perfil farmococinetico mejorado de sustancias hidrofobas
NZ335133A (en) Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof for treating cancer
AU1023788A (en) Therapeutic system for sparingly soluble active ingredients
IL150528A0 (en) Ibuprofen containing active agent preparation
AU1079701A (en) Oral transmucosal drug dosage using solid solution
DE69422921D1 (de) Vorrichtung zum verabreichen von pharmazeutischen substanzen
EP1008380A3 (en) Process and apparatus for mixing or dispersing liquids
NZ527532A (en) Pharmaceutical formulation comprising bicalutamide
DE69505677D1 (de) Liposomales verabreichungssystem für biologisch aktive stoffe
PT703786E (pt) Utilizacao de nonapeptideos e decapeptideos para a preparacao de um medicamento para o tratamento da sida
AU4246296A (en) Methods and apparatus for making liposomes containing hydrophobic drugs
DE69827631D1 (en) Infusionsdüse
MXPA03009984A (es) PREPARACION PARA LA REMOCIoN DE MATERIAL QUERATINOSO ANORMAL.
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
AU2001255044A1 (en) Electrically-mediated transdermal drug injection
ES2165017T3 (es) Preparacion inhibidora de la 5alfa-reductasa para administracion oral, proceso para su produccion y uso de la misma.
EP1288311A3 (en) Method for testing small pharmaceutically active molecules in the activation of Pax4 and production of insulin producing beta-cells
ATE145334T1 (de) Onconase und cisplatin, melphalan und adriamycin enthaltende arzneimittel